Funded Tech Companies
OriCell Therapeutics
Wondering who provided funding to OriCell Therapeutics? Qiming Ventures, RTW Investments and C&D Emerging Investment put venture money into this innovative biopharmaceutical company.
Company Overview
Company Name
OriCell Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3F Bldg 1, No. 1227 Zhangheng Rd, Pudong,
Shanghai, 200120
CN
Shanghai, 200120
CN
Phone
Website
Email Address
Company Background Information
Overview
Founded in 2015, OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives to become the world-leading developer of novel drugs for tumor immunotherapy. We have received a pre-A round exclusive investment of nearly 100 million yuan from Qiming Venture Partners at the end of 2019 and completed the A round of financing worth over 200 million Yuan at the end of 2020.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/28/2023
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yang Huanfeng
Chief Scientific Officer
He Xiaowen
Chief Technical Officer
Weidong Cui
Company Investors
- Qiming Ventures
- RTW Investments
- C&D Emerging Investment
- Qatar Investment Authority
- Quan Capital
Browse more funded tech companies:
ORIC Pharmaceuticals | Oricula Therapeutics
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs